Liposomal encapsulation technology uses lipid bilayer vesicles (liposomes) to associate a drug with a carrier system and control measurable properties such as loading, size distribution, and stability.
A “liposomal” claim is a structural claim about the delivery system, not a guaranteed performance claim.
In supplements, ‘liposomal’ means an ingredient is formulated in phospholipid vesicles (liposomes) built from phospholipid bilayers.
Liposomes and lipid nanoparticles (LNPs) are both lipid-based delivery systems, but they are optimized for different payloads and development constraints.